4.7 Article

Epigenetic and transcriptional control of interferon-β

期刊

JOURNAL OF EXPERIMENTAL MEDICINE
卷 218, 期 9, 页码 -

出版社

ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20210039

关键词

-

资金

  1. National Institutes of Health [T32 AI134632, F31HL152706, R01AI148416-S1, R01AI148416]
  2. STARR Cancer Consortium [I14-0020]

向作者/读者索取更多资源

Interferons play a crucial role in inhibiting viral replication and are associated with autoimmune diseases and infections. Researchers have focused on the transcriptional regulation of interferons, particularly emphasizing the assembly and function of factors that regulate IFN-beta enhancer activity.
The three classes of interferons (IFNs) share the ability to inhibit viral replication, activating cell transcriptional programs that regulate both innate and adaptive responses to viral and intracellular bacterial challenge. Due to their unique potency in regulating viral replication, and their association with numerous autoimmune diseases, the tightly orchestrated transcriptional regulation of IFNs has long been a subject of intense investigation. The protective role of early robust IFN responses in the context of infection with SARS-CoV-2 has further underscored the relevance of these pathways. In this viewpoint, rather than focusing on the downstream effects of IFN signaling (which have been extensively reviewed elsewhere), we will summarize the historical and current understanding of the stepwise assembly and function of factors that regulate IFN beta enhancer activity (the enhanceosome) and highlight opportunities for deeper understanding of the transcriptional control of the ifnb gene.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据